Pathobiochemical implications of hyperdopaminuria in patients with aromatic L-amino acid decarboxylase deficiency.
Abeling
N G
NG
Academic Medical Center, University of Amsterdam, Department of Clinical Chemistry and Division Emma Children's Hospital, The Netherlands. abeling@amc.uva.nl
Bräutigam
C
C
Hoffmann
G F
GF
Barth
P G
PG
Wevers
R A
RA
Jaeken
J
J
Fiumara
A
A
Knust
A
A
van Gennip
A H
AH
D015102:3,4-Dihydroxyphenylacetic Acid / Q000652:urine; D001142:Aromatic-L-Amino-Acid Decarboxylases / Q000172:deficiency*; D004298:Dopamine / Q000031:analogs & derivatives / Q000652:urine*; D006719:Homovanillic Acid / Q000652:urine; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use
D015102:3,4-Dihydroxyphenylacetic Acid; D007980:Levodopa; D001142:Aromatic-L-Amino-Acid Decarboxylases; C001746:3-methoxytyramine; D004298:Dopamine; D006719:Homovanillic Acid